Drug Treatment of Atrial Flutter in Children
Links shared publicly online about this topic
FDA Approves Multaq for Patients with Atrial Fibrillation or Atrial Flutter
drugs.com — “Multaq (dronedarone) is used to treat atrial fibrillation and atrial flutter. Includes Multaq side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 9, 2009 at 12:40 pm By:
FDA approves drug for patients with atrial fibrillation http://tinyurl.com/n6442q
FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter
medicalnewstoday.com — “Sanofi-aventis (euronext: san and nyse: sny) announced that the u.s. food and drug administration (fda) has approved multaq(r) (dronedarone) 400 mg tablets. patients with atrial fibrillation (af)” View full resource at medicalnewstoday.com
Most Recently Shared on July 3, 2009 at 12:19 pm By:
MedicalNewsToday: FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or: http://tinyurl.com/lzkkyz Full http://tinyurl.com/ks672v
Clinical Trials Update: April 28 2010 - MSN Health & Fitness - Medications
health.msn.com — “Depression Rheumatoid Arthritis Atrial Fibrillation Heart Flutter HealthDay News -- Here are the latest clinical trials courtesy of ClinicalConne” View full resource at health.msn.com
Most Recently Shared on April 28, 2010 at 5:18 pm By:
Procainamide (Pronestyl, Procan-SR, Procanbid) Drug Information by MedicineNet.com
medicinenet.com — “Information about procainamide (pronestyl, procan-sr, procanbid), a drug prescribed for the treatment of abnormal heart rhythms, for example, atrial fibrillation and flutter, tachycardias, and premature heart beats.” View full resource at medicinenet.com
Most Recently Shared on September 10, 2009 at 8:29 pm By:
MedicineNet: procainamide, Pronestyl; Procan-SR; Procanbid http://bit.ly/5MzL6 Full http://bit.ly/N5C5P
FDA Approves Multaq to Treat Heart Rhythm Disorder
fda.gov — “The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders). The drug is approved to be used in patients whose hearts have returned to normal rhythm or who will undergo drug or electric-shock treatment to restore a normal heart beat.” View full resource at fda.gov
Most Recently Shared on July 2, 2009 at 4:52 pm By:
FDA Approves Multaq to Treat Heart Rhythm Disorder http://bit.ly/iEJVQ
FDA Approves Multaq To Treat Heart Rhythm Disorder
medicalnewstoday.com — “The u.s. food and drug administration has approved multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhy” View full resource at medicalnewstoday.com
Most Recently Shared on July 5, 2009 at 10:13 am By:
MedicalNewsToday: FDA Approves Multaq To Treat Heart Rhythm Disorder http://tinyurl.com/lzkkyz Full http://tinyurl.com/nbkzvn
Rare Severe Liver Injury Risk Warning Added To Multaq (dronedarone) Labels
medicalnewstoday.com — “Two cases of acute liver failure in which the patients taking heart medication dronedarone (Multaq) needed liver transplants have resulted in an FDA communication informing that data on the potent” View full resource at medicalnewstoday.com
Most Recently Shared on January 17, 2011 at 6:03 pm By:
Rare Severe Liver Injury Risk Warning Added To Multaq (dronedarone) Labels Two cases of acute liver failure in which th.. http://dld.bz/Gkva
Stereotaxis Is Notified Of The FDA Approval Of An Additional Magnetic Irrigated Catheter
medicalnewstoday.com — “Stereotaxis (nasdaq: stxs) announced that the celsius® rmt thermocool® catheter has been approved by the u.s. food and drug administration for use with stereotaxis' magnetic navigation sys” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2010 at 12:37 pm By:
Stereotaxis Is Notified Of The FDA Approval Of An Additional Magnetic Irrigated Catheter Stereotaxis (Nasdaq: STXS) a.. http://bit.ly/5x5l2z
Medical News: FDA Approves Heart Drug After New Trials - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the antiarrhythmic dronedarone (Multaq) for treatment of atrial fibrillation and atrial flutter, the drug's developer announced today.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2009 at 9:55 pm By:
FDA• FDA Approves Heart Drug After New Trials http://tinyurl.com/kqfex3
Dronedarone approved
theheart.org — “Dronedarone is envisioned as a safer alternative to amiodarone, a widely used antiarrhythmic agent in patients with AF.” View full resource at theheart.org
Most Recently Shared on July 2, 2009 at 4:35 pm By:
heartwire: FDA approves dronedarone for atrial fibrillation http://bit.ly/4eV82V
FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system
news-medical.net — “Stereotaxis announced that the Celsius® RMT ThermoCool® catheter has been approved by the U.S. Food and Drug Administration for use with Stereotaxis' magnetic navigation system for the treatment of Type 1 atrial flutter. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for mapping and ablation.” View full resource at news-medical.net
Most Recently Shared on January 12, 2010 at 12:00 pm By:
FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system: Stereotaxis ann... http://bit.ly/8DNczp
European guidelines back use of Sanofi's Multaq http://bit.ly/aIJYQ1
health.yahoo.net — “European guidelines back use of Sanofi's Multaq http://bit.ly/aIJYQ1” View full resource at health.yahoo.net
Most Recently Shared on August 29, 2010 at 10:16 am By:
European guidelines back use of Sanofi's Multaq http://bit.ly/aIJYQ1
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Vericom Corporation
A leading audio and visual communications provider for healthcare organizations. Follow us for news about healthcare, technology, and marketing.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
msn
Advertisement

